Abortion Pills and the Politics of Delayed Action The Louisiana Supreme Court has put efforts to ban telehealth access to mifepristone on hold, but the state is pressing forward with an attempt to bypass federal regulations.
At stake is the future of medication abortion protocols in the United States. Louisiana's argument centers on the 2023 FDA rules allowing telehealth access to mifepristone.
The state claims that these rules were enacted arbitrarily and capriciously, violating the Comstock Act, a 19th century obscenity law with implications for national abortion policy.